the tumor data (progression, partial response, complete remission) is not clean
DUE TO Risk Causes
various reasons
THEN Risk Impact MAY RESULT
an extended study duration, unnecessary additional enrollment, and the treatment of Subjects with inadequate treatment options
Risk Indicator
High Percentage of Tumor Data Issues
Metric
Percent of Non-usable Tumor assessments
Unit
%
What level should be measured
Study, Country, Site, Subject
Purpose
Optimize the accuracy and reliability of tumor data, supporting evidence-based clinical decisions, advancing oncology research, and improving Subject outcomes.
Description
KRI monitors the occurrence of issues or discrepancies in the collection, documentation, or interpretation of tumor-related data, ensuring data accuracy for effective oncology research and Subject care.
Formula
Divide a number of tumor data issues by a total number of tumor data entries, multiply by 100%.
Suggested Thresholds - High
>10 %
Suggested Thresholds - Medium
>5 %
Associated Metric 1
Number of tumor data issues
Associated Metric 2
Number of tumor data entries
Do you like the KRI description?Thanks for the feedbackThere was a problem submitting your feedback. Please try again later.